ProCE Banner Activity

CCO’s Conference to Clinic Highlights From ASH 2024 Annual Meeting: Classical Hematology

Conference Coverage
Slideset

Download this slideset covering key clinically relevant studies on nonmalignant hematologic disorders including GVHD, thrombosis, hemostasis, and red blood cell disorders presented at the ASH 2024 annual meeting.

Released: January 17, 2025

Expiration: July 16, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

This educational activity is supported by independent medical educational grants from AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Incyte Corporation, Lilly, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Bristol Myers Squibb

GlaxoSmithKline

Incyte Corporation

Lilly

Novartis Pharmaceuticals Corporation